Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

Brain imaging of dopamine D2/D3 receptors of 18F-fallypride-PET in normal volunteers: An AMIC Ray-Scan 64 PET/CT clinical system clinical trial

Kedi Zhou, Zhe Guo, Jinming Zhang, Jiahe Tian and Qiushi Ren
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1626;
Kedi Zhou
1Department of Biomedical Engineering, Peking University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhe Guo
2Department of Nuclear Medicine, The Chinese PLA General Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinming Zhang
2Department of Nuclear Medicine, The Chinese PLA General Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiahe Tian
2Department of Nuclear Medicine, The Chinese PLA General Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiushi Ren
1Department of Biomedical Engineering, Peking University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1626

Objectives The dysfunction of dopamine system, a neurotransmission mode playing important roles in human brain, is implicated in many disorders in nervous system, such as Parkinson’s disease (PD), Attention Deficit Hyperactivity Disorder (ADHD). 18F-fallypride is a radioactive molecular probe for Positron Emission Tomography (PET) visualizing the Dopamine D2/D3 receptors in striatal and extrastriatal areas1-3. We investigated the visualization of dopamine D2/D3 receptors by 18F-fallypride in normal volunteers by using AMIC Ray-Scan 64 PET/CT (CFDA approved) developed by our group.

Methods 15 normal volunteers (8 males and 7 females) were investigated with AMIC Ray-Scan 64 PET/CT. The 18F-fallypride was injected intravenously (2.96MBq/kg) to normal volunteer 1 hour prior to PET/CT brain scanning. Image reconstruction and data analysis was performed by using AMIC Ray-Scan 64 PET/CT software.

Results Reconstructed by AMIC Ray-Scan 64 PET/CT software, the image of dopamine system in extrastriatal areas including substantia nigra and red nucleus is visualized clearly, and signal distribution of 18F-fallypride in caudate nucleus and putamen in left and right side is homogeneous and symmetrical in normal volunteers’ brain scanning (result is depicted in supplement Figure).

Conclusions 18F-fallypride-PET/CT scanning is a promising method in visualizing of neurotransmitters like dopamine receptors due to the long half-life and its strong signal, comparing to other radiotracers. In this study, we confirmed that the AMIC Ray-Scan 64 PET/CT system, as well as 18F-fallypride, performs excellently in dopamine D2/D3 receptors imaging in normal volunteers. Thus, this Ray-Scan system could be widely used in nervous system disease diagnosis and drug discovery, as well as other clinical applications.

Research Support The research is supported by National Key Instrumentation Development Project (2011YQ030114), Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81421004), and Special High-performance Medical Diagnostic Equipment Program (2013) from Development and Reform Commission in China.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Brain imaging of dopamine D2/D3 receptors of 18F-fallypride-PET in normal volunteers: An AMIC Ray-Scan 64 PET/CT clinical system clinical trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Brain imaging of dopamine D2/D3 receptors of 18F-fallypride-PET in normal volunteers: An AMIC Ray-Scan 64 PET/CT clinical system clinical trial
Kedi Zhou, Zhe Guo, Jinming Zhang, Jiahe Tian, Qiushi Ren
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1626;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Brain imaging of dopamine D2/D3 receptors of 18F-fallypride-PET in normal volunteers: An AMIC Ray-Scan 64 PET/CT clinical system clinical trial
Kedi Zhou, Zhe Guo, Jinming Zhang, Jiahe Tian, Qiushi Ren
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1626;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences

  • PET CT Quantification to direct Alzheimer’s patients to anti-amyloid therapy
  • Multicenter trial study for usefulness of physical parameters toward the standardization of brain SPECT image: relation to visual analysis
  • Assessment of Brain Perfusion 123I-IMP SPECT imaging Using Low Energy High Resolution Collimator image reconstructed by Flash 3D
Show more Neurosciences

MTA II: Psychiatry Posters

  • Glutamatergic Abnormalities in a Rodent Model of Alcohol Abuse
  • The role of Phosphodiesterase 10A in Schizophrenia: A Positron Emission Tomography study using [11C]IMA107
  • Evaluation of 99mTC-ECD SPECT/CT Brain Imaging with Scenium Analysis in Patients with Generalized Anxiety Disorder
Show more MTA II: Psychiatry Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire